Back to Search Start Over

Is photodynamic therapy a relevant therapeutic option in refractory benign familial pemphigus (Hailey–Hailey disease)? A series of eight patients

Authors :
Olivier Dereure
Maha Alsahli
Aurélie Du Thanh
Céline Girard
A. Debu
Didier Bessis
Bernard Guillot
Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)
Pathogénèse et contrôle des infections chroniques (PCCI)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Universitaire de Montpellier (CHU Montpellier )-Université de Montpellier (UM)
Source :
Journal of Dermatological Treatment, Journal of Dermatological Treatment, Informa Healthcare, 2017, 28 (7), pp.678-682. ⟨10.1080/09546634.2017.1308461⟩
Publication Year :
2017
Publisher :
Informa UK Limited, 2017.

Abstract

Treatment of benign familial pemphigus or Hailey-Hailey disease (HHD), a rare inherited condition associated with a significant impairment of quality of life, is often challenging and disappointing with frequent relapses and infectious complications. Topical photodynamic therapy (PDT) may offer new perspectives in this difficult setting.Eight patients with long-lasting HHD lesions refractory to multiple treatments were treated on at least one involved site with PDT using methyl-amino levulinate with a standardized protocol of three sessions of irradiation separated by 3-week intervals.A complete or partial clearing was achieved in all treated areas, and the result was satisfactorily maintained in all cases after a follow-up period ranging from 3 to 36 months. Results were of higher quality in non-inguinal areas. Tolerance was overall acceptable with local pain during and shortly after irradiation being the main limiting factor.Our series, although limited in size, emphasizes the interest of PDT in this difficult condition even though results may be incomplete. Treatment-related pain can be adequately managed by prior analgesics, cooling with sprayed water and local tumescent anesthesia. Overall, PDT appears as a relevant option in refractory HHD management with a favorable benefit/risk ratio.

Details

ISSN :
14711753 and 09546634
Volume :
28
Database :
OpenAIRE
Journal :
Journal of Dermatological Treatment
Accession number :
edsair.doi.dedup.....52821f085864f98a7686217ba3b95293